|
Arthur D. Levinson, Ph.D.
Chairman and Chief Executive Officer
Dr. Levinson became chief executive officer of Genentech and joined the board of directors in July 1995. He was named chairman of the board in 1999. Levinson joined the company in 1980 as a senior scientist and subsequently held the position of staff scientist. He was named senior vice president of Research and Development in 1993 and president in 1995. He has been a member of Genentech's executive management team since 1990. Prior to his employment with Genentech, Levinson was a postdoctoral fellow in the department of microbiology at the University of California, San Francisco.
Susan D. Desmond-Hellmann, M.D., M.P.H.
President,
Product Development
Dr. Hellmann was named president of Product Development in 2004. She joined Genentech in 1995 as a clinical scientist and was named executive vice president, Development and Product Operations in 1999. Prior to joining Genentech, Hellmann was associate director of clinical cancer research at Bristol-Myers Squibb's Pharmaceutical Research Institute. Trained as an oncologist, Hellmann spent several years treating patients in the clinical setting.
Ian T. Clark
Executive Vice President,
Commercial
Mr. Clark joined Genentech's executive
committee in August 2005 as senior vice
president, Commercial and was promoted
to executive vice president, Commercial in
December 2005. Clark first came to Genentech
in January 2003 as senior vice president
and general manager, BioOncology. Prior to
joining Genentech, Clark served as president
of Novartis Canada. Before assuming his post
in Canada, Clark served as chief operating
officer for Novartis United Kingdom.
David A. Ebersman
Executive Vice President
and Chief Financial Officer
Mr. Ebersman assumed the chief financial officer position in March 2005. He
was promoted to executive vice president in December 2005. Ebersman joined Genentech in 1994 as a business development analyst. During the next several years, he was promoted to positions of
increasing responsibility in Business Development, Product Development and Product Operations. Ebersman served as senior vice president, Product Operations and, most recently, as senior vice
president, Finance.
|
|
Stephen G. Juelsgaard, D.V.M., J.D.
Executive Vice President, Secretary
and Chief Compliance Officer
Mr. Juelsgaard was promoted to executive
vice president in September 2002 and
named chief compliance officer in 2005.
He joined Genentech in 1985 as corporate
counsel. In 1993 he became vice president,
Corporate Law, and in 1994 he was named
vice president and general counsel. He was
named secretary in 1997 and senior vice
president in 1998.
Richard H. Scheller, Ph.D.
Executive Vice President,
Research
Dr. Scheller was promoted to executive vice president, Research in September 2003 after joining Genentech in 2001 as senior vice president, Research. In addition to his work at Genentech, Scheller is an adjunct professor in the Department of Biochemistry and Biophysics,
School of Medicine, University of California, San Francisco. Scheller has published more than 200 papers in peer-reviewed scientific journals. Prior to joining Genentech, Scheller served
as professor of Molecular and Cellular Physiology and of Biological Sciences at the Stanford University Medical Center and as an investigator with the Howard Hughes Medical Institute.
Patrick Y. Yang, PH.D.
Executive Vice President,
Product Operations
Dr. Yang was promoted to executive vice president in December 2005. He joined Genentech in 2003 as vice president, South San Francisco Manufacturing and Engineering and was named senior vice president, Product Operations in January 2005. He became a member of the Executive Committee in July 2005. Prior to joining Genentech, Yang spent 11 years at Merck & Company in various leadership positions, including vice president, Supply Chain Management and vice president, Asia/Pacific Manufacturing Operations. Prior to Merck, Yang worked for General Electric for 12 years in engineering and manufacturing.
|
